Efficacy and safety of high-dose propranolol for the management of infant supraventricular tachyarrhythmias

Journal of Pediatrics

Volumn 166, Issue 1, 2015, Pages 115-118

  Barton, Andrea L ^a   Moffett, Brady S ^a,b   Valdes, Santiago O ^b   Miyake, Christina ^b   Kim, Jeffrey J ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

SA Supraventricular arrhythmia; SVT Supraventricular tachycardia; WPW Wolff parkinson white

Indexed keywords

AMIODARONE; DIGOXIN; FLECAINIDE; PROPRANOLOL; SOTALOL; ANTIARRHYTHMIC AGENT;

ARTICLE; BRADYCARDIA; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; HUMAN; HYPOGLYCEMIA; HYPOTENSION; INFANT; INFANT DISEASE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT INFORMATION; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT DURATION; NEWBORN; RECURRENT DISEASE; TACHYCARDIA, SUPRAVENTRICULAR; TIME; TREATMENT OUTCOME;

ANTI-ARRHYTHMIA AGENTS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROPRANOLOL; RECURRENCE; RETROSPECTIVE STUDIES; TACHYCARDIA, SUPRAVENTRICULAR; TIME FACTORS; TREATMENT OUTCOME;

EID: 84922016695     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.08.067     Document Type: Article

References (8)

1. Wong KK, Potts JE, Etheridge SP, Sanatani S. Medications used to manage supraventricular tachycardia in the infant a North American survey. Pediatr Cardiol 2006;27:199-203.
2. Gillette P, Garson A Jr, Eterovic E, Neches W, Mullins C, McNamara DG. Oral propranolol treatment in infants and children. J Pediatr 1978;92:141-4.
3. Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, et al. Flecainide as first-line treatment for supraventricular tachycardia in newborns. J Cardiovasc Med (Hagerstown) 2009;10:372-5.
4. Ko JK, Ban JE, Kim YH, Park IS. Long-term efficacy of atenolol for atrioventricular reciprocating tachycardia in children less than 5 years old. Pediatr Cardiol 2004;25:97-101.
5. O'Sullivan JJ, Gardiner HM, Wren C. Digoxin or flecainide for prophylaxis of supraventricular tachycardia in infants? J Am Coll Cardiol 1995;26:991-4.
6. Tavera MC, Bassareo PP, Neroni P, Follese C, Manca D, Montis S, et al. Supraventricular tachycardia in neonates: antiarrhythmic drug choice dilemma. J Matern Fetal Neonatal Med 2010;23(Suppl 3):30-3.
7. Sanatani S, Potts JE, Reed JH, Saul JP, Stephenson EA, Gibbs KA, et al. The study of antiarrhythmic medications in infancy (SAMIS): a multicenter, randomized controlled trial comparing the efficacy and safety of digoxin versus propranolol for prophylaxis of supraventricular tachycardia in infants. Circ Arrhythm Electrophysiol 2012;5:984-91.
8. Pickoff AS, Zies L, Ferrer PL, Tamer D, Wolff G, Garcia O, et al. Highdose propranolol therapy in the management of supraventricular tachycardia. J Pediatr 1979;94:144-6.